Drug discovery and development in tuberculosis

In the history drugs are discovered through the active ingredients from age old remedies, but during the present day’s disease are controlled by molecular and physiological level. The healthy approach towards discovering new drugs also measures to reduce the prolonged clinical development of new drugs.it involves the details about the preclinical and clinical trials of tuberculosis. Antibiotic drugs became shortage due to multiple drug resistance which is main cause of tuberculosis. New drug discovery uses the inactive bacteria to develop new drug for tuberculosis. Mycobacterium is resistant to most the antibiotics. To achieve the shorter duration therapy it is expected to destroy the sub population of mycobacterium.



<p style="\&quot;margin-left:" 58.5pt;="" text-align:="" justify;\"="">

  • Clinical trials
  • TB Drug development
  • Optimizing drug activity against pathogen
  • TB drug pipeline
  • TB therapy

Related Conference of Drug discovery and development in tuberculosis

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Drug discovery and development in tuberculosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in